Join
Live feed
·
PRReleasevia Quantisnow
Kiromic BioPharma Inc. logo

Kiromic Announces the Acquisition of InSilico Solutions Leveraging on Bioinformatics and Artificial Intelligence to Advance Clinical Development on Its Outpatient Allogeneic CAR-T for Solid Tumors

ByQuantisnow·Wall Street's wire, on your screen.
KRBP· Kiromic BioPharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KRBP (Kiromic BioPharma Inc.) and more on Quantisnow.